Stockreport

Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $555 million and $1.9 billion for the fourth quarter and full year 2025, respectivelySu [Read more]